HSBC Holdings
QTTB icon

HSBC Holdings’s Q32 Bio QTTB Stock Holding History

HSBC Holdings’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-863
Closed -$9.32K – 3270
2023
Q4 		$9.32K Hold
863
– – ﹤0.01% 2694
2023
Q3 		$17.7K Hold
863
– – ﹤0.01% 2675
2023
Q2 		$14K Hold
863
– – ﹤0.01% 2527
2023
Q1 		$15.9K Hold
863
– – ﹤0.01% 2615
2022
Q4 		$17.6K Hold
863
– – ﹤0.01% 3020
2022
Q3 		$25K Sell
863
-95
-10% -$3.87K ﹤0.01% 2865
2022
Q2 		$35K Sell
958
-11
-1% -$376 ﹤0.01% 3165
2022
Q1 		$52K Buy
969
+11
+1% +$683 ﹤0.01% 3197
2021
Q4 		$63K Buy
+958
New +$93K ﹤0.01% 3186

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings's QTTB Position: Q1 2024 in Review

HSBC Holdings sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 863 shares — an estimated $9.32K sold.

HSBC Holdings first reported a position in QTTB in Q4 2021 and held it in 9 quarters. The position peaked at $63K in Q4 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • HSBC Holdings reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • HSBC Holdings sold 863 Q32 Bio shares in Q1 2024, an estimated $9.32K.
  • HSBC Holdings first reported a position in Q32 Bio in Q4 2021 and held it in 9 quarters.
  • HSBC Holdings's Q32 Bio position peaked at $63K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.